| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.SEMARTHRIT.2012.12.002 |
| P8608 | Fatcat ID | release_hs6fpwm255hfpbozgrftemenie |
| P698 | PubMed publication ID | 23422269 |
| P5875 | ResearchGate publication ID | 235668716 |
| P50 | author | Karen H Costenbader | Q87706447 |
| P2093 | author name string | Sara R Schoenfeld | |
| Shanthini Kasturi | |||
| P433 | issue | 1 | |
| P921 | main subject | epidemiology | Q133805 |
| patient | Q181600 | ||
| cardiovascular disease | Q389735 | ||
| systematic review | Q1504425 | ||
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 77-95 | |
| P577 | publication date | 2013-02-17 | |
| P1433 | published in | Seminars in Arthritis and Rheumatism | Q15761553 |
| P1476 | title | The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review | |
| P478 | volume | 43 |
| Q39337396 | 25-hydroxyvitamin D is associated with metabolic syndrome among premenopausal women with systemic lupus erythematosus in China |
| Q40644781 | An Investigation into the Scale and Impact of Self-Reported Foot Problems Associated with Systemic Lupus Erythematosus: A Study Protocol and Survey Questionnaire Development. |
| Q39017583 | Association between ischemic heart disease and systemic lupus erythematosus-a large case-control study |
| Q64082219 | Association between periodontitis and cardiometabolic risk: Results from the Korean National Health and Nutrition Examination Survey 2008-2014 |
| Q35530495 | Bone mineral density and carotid atherosclerosis in systemic lupus erythematosus: a controlled cross-sectional study. |
| Q40513776 | Brief Report: Trends in Hospitalizations Due to Acute Coronary Syndromes and Stroke in Patients With Systemic Lupus Erythematosus, 1996 to 2012 |
| Q64114060 | Cardiac phenotype in mouse models of systemic autoimmunity |
| Q36153524 | Cardiovascular Events in Systemic Lupus Erythematosus: A Nationwide Study in Spain From the RELESSER Registry |
| Q37330468 | Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review. |
| Q34081242 | Cardiovascular involvement in autoimmune diseases |
| Q90415557 | Cerebrovascular Events in Systemic Lupus Erythematosus: Diagnosis and Management |
| Q34424626 | Challenges in understanding the role of pregnancy morbidity in cardiovascular risk in SLE. |
| Q27331466 | Cholesterol-induced non-alcoholic fatty liver disease and atherosclerosis aggravated by systemic inflammation |
| Q92006099 | Comparison of PREDICTS atherosclerosis biomarker changes after initiation of new treatments in patients with SLE |
| Q92286651 | Concomitant Ro/SSA and La/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjögren's syndrome |
| Q30248866 | Current Perspectives on Arthroplasty in Systemic Lupus Erythematosus: Rates, Outcomes, and Adverse Events |
| Q40047389 | Drugs used in incident systemic lupus erythematosus - results from the Finnish nationwide register 2000-2007. |
| Q61448361 | Early diagnosis of cardiac involvement in systemic lupus erythematosus via global longitudinal strain (GLS) by speckle tracking echocardiography |
| Q36126483 | Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus |
| Q36139802 | Effect of Systemic Lupus Erythematosus on the Risk of Incident Respiratory Failure: A National Cohort Study |
| Q57830832 | Immune-Mediated Inflammatory Rheumatic Diseases |
| Q40549097 | Impact of Disease Duration on Vascular Surrogates of Early Atherosclerosis in Childhood-Onset Systemic Lupus Erythematosus |
| Q90133680 | In-hospital mortality in patients with systemic lupus erythematosus: a study from Jordan 2002-2017 |
| Q35070613 | Insights into aortic sclerosis and its relationship with coronary artery disease |
| Q38877052 | Insights into the epidemiology and management of lupus nephritis from the US rheumatologist's perspective |
| Q90390566 | LOX-1: A potential driver of cardiovascular risk in SLE patients |
| Q52592135 | Lipid Testing and Statin Prescription among Medicaid Recipients with Systemic Lupus Erythematosus, Diabetes Mellitus and the General Medicaid Population. |
| Q28547208 | Long-term frequent use of non-steroidal anti-inflammatory drugs might protect patients with ankylosing spondylitis from cardiovascular diseases: a nationwide case-control study |
| Q88310736 | Managing premature atherosclerosis in patients with chronic inflammatory diseases |
| Q91818936 | Novel Self-Report Tool for Cardiovascular Risk Assessment |
| Q52668758 | Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis. |
| Q46361889 | Paediatric rheumatology: where are the innovations in paediatric rheumatology? |
| Q38230699 | Pathogenesis and treatment of atherosclerosis in lupus |
| Q36859757 | Patient-Reported Outcomes in Systemic Lupus Erythematosus |
| Q92464625 | Perioperative medical management for patients with RA, SPA, and SLE undergoing total hip and total knee replacement: a narrative review |
| Q53694045 | Phenome-wide association study identifies marked increased in burden of comorbidities in African Americans with systemic lupus erythematosus. |
| Q45638947 | Physical activity and sedentary behavior in patients with systemic lupus erythematosus and rheumatoid arthritis |
| Q50637234 | Prevalence of vascular disease in systemic lupus erythematosus compared with type-1 diabetes mellitus: a cross-sectional study of two cohorts. |
| Q35204001 | Prevalence, risk factors and associations of primary Raynaud's phenomenon: systematic review and meta-analysis of observational studies |
| Q35994802 | Preventing Heart Failure in Inflammatory and Immune Disorders |
| Q57260319 | Psoriasis and risk of heart failure: a nationwide cohort study |
| Q48636445 | Race/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus |
| Q90000657 | Risk factors for progression of carotid intima-media thickness in patients with systemic lupus erythematosus: protocol for an observational cohort study in China |
| Q38404919 | Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Cutaneous Lupus Erythematosus: A Population-Based Cohort Study |
| Q38764974 | Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study. |
| Q36299359 | Risk of Peripheral Arterial Occlusive Disease in Patients With Systemic Lupus Erythematosus: A Nationwide Population-Based Cohort Study |
| Q41910493 | Serum alpha-actinin antibody status in systemic lupus erythematosus and its potential in the diagnosis of lupus nephritis |
| Q47671088 | Sex, Symptom Severity, and Quality of Life in Rheumatology |
| Q89868356 | Similar progression of carotid intima-media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower HDL levels, hypertension, history of lupus nephritis and a higher pre |
| Q39632598 | Sucrose non-fermenting AMPK related kinase/Pentraxin 3 and DNA damage axis: a gateway to cardiovascular disease in systemic lupus erythematosus among Egyptian patients |
| Q89314644 | Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases |
| Q55282858 | Systemic Lupus Erythematosus in Primary Care: An Update and Practical Messages for the General Practitioner. |
| Q39053129 | Systemic lupus erythematosus diagnosis and management |
| Q28069667 | The Sphinx's riddle: cardiovascular involvement in autoimmune rheumatic disease |
| Q47610317 | The Use of Primary Prevention Statin Therapy in Those Predisposed to Atherosclerosis |
| Q39283399 | The evolving concept of SLE comorbidities. |
| Q91803860 | The majority of Swedish systemic lupus erythematosus patients are still affected by irreversible organ impairment: factors related to damage accrual in two regional cohorts |
| Q30886508 | Thrombolytic therapy at systemic lupus onset with secondary antiphospholipid syndrome. A rare stroke experience |
| Q50092295 | Unchanging premature mortality trends in systemic lupus erythematosus: a general population-based study (1999-2014). |
| Q49722994 | Weighing the Anti-Ischemic Benefits and Bleeding Risks from Aspirin Therapy: a Rational Approach |
| Q39000849 | miRNA-451a Targets IFN Regulatory Factor 8 for the Progression of Systemic Lupus Erythematosus |
Search more.